BDBM50268070 CHEMBL4101409

SMILES: Cl.Cl.CN(Cc1cccc(c1)-c1cnc(nc1)N1CCC(CCC(O)=O)CC1)C(=O)CN

InChI Key: InChIKey=BYKCVBDHVUZGRP-UHFFFAOYSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50268070   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Membrane primary amine oxidase (Homo sapiens (Human))	BDBM50268070 (CHEMBL4101409) Show SMILES Cl.Cl.CN(Cc1cccc(c1)-c1cnc(nc1)N1CCC(CCC(O)=O)CC1)C(=O)CN Show InChI InChI=1S/C22H29N5O3/c1-26(20(28)12-23)15-17-3-2-4-18(11-17)19-13-24-22(25-14-19)27-9-7-16(8-10-27)5-6-21(29)30/h2-4,11,13-14,16H,5-10,12,15,23H2,1H3,(H,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. Electronic address: susumu.yamaki@astellas.com. Curated by ChEMBL					Assay Description Inhibition of human VAP-1 expressed in CHO cells using 14C-benzylamine as substrate preincubated for 20 mins followed by substrate addition measured ...				Bioorg Med Chem 25: 4110-4122 (2017) Article DOI: 10.1016/j.bmc.2017.05.059 BindingDB Entry DOI: 10.7270/Q21Z46W7
					More data for this Ligand-Target Pair